dc.contributor.author |
Basavanna, V |
|
dc.contributor.author |
Ningaiah, S |
|
dc.contributor.author |
Chandramouli, M |
|
dc.contributor.author |
Sobha, A |
|
dc.contributor.author |
Doddamani, S |
|
dc.date.accessioned |
2021-10-27T08:16:09Z |
|
dc.date.available |
2021-10-27T08:16:09Z |
|
dc.date.issued |
2021-07 |
|
dc.identifier.citation |
Journal of the Iranian Chemical Society; 18(7):1479-1522 |
en_US |
dc.identifier.uri |
https://link.springer.com/article/10.1007/s13738-020-02152-1#citeas |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/3840 |
|
dc.description.abstract |
In the recent decade, the study on N-heterocycles has dramatically increased due to its versatility in many significant fields and because of its distinctive battle which is associated with the bioassay and its interaction with the cells. These novel heterocycles are designed and synthesized by chemists through new strategies on par with the reported methods. Subsequently, the synthesized molecules were screened for their efficacy against the typical drugs in the market. In this article, recently unveiled pharmacologically important quinoline allied pyrazoles have been reviewed. Moreover, this review gives a bird’s-eye view of different methods adopted for synthesis in addition to the conventional approaches and also detailed study of the bioactive quinolinyl-pyrazole heterocycle when compared with standard drug-associated/having efficient molecule. We believe that this review will inspire synthetic as well as medicinal chemists who are in quest of less toxic and more potent quinolinyl-pyrazoles for the treatment of various health threats. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Springer |
en_US |
dc.title |
Quinolinyl-pyrazoles: synthesis and pharmacological evolution in the recent decennial |
en_US |
dc.type |
Article |
en_US |